TrialBritish journal of cancer2011

Cost-effectiveness analysis of trastuzumab to treat HER2-positive advanced gastric cancer based on the randomised ToGA trial.

T Shiroiwa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.